InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,148.00
(
-0.09%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
85.38
(
0.31%
)
Bitcoin
62,725.07
(
0.20%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rurik

Send PM Follow Ignore
Followers 2
Posts 597
Boards Moderated 0
Alias Born 05/29/2011

rurik

Re: vidpok45 post# 26072

Friday, 02/01/2013 9:25:11 AM

Friday, February 01, 2013 9:25:11 AM

Post# of 80490
Gilead doesn't have 11 billion to poney up. They are still in the hole for the Pharmasset acquisition with a huge debt and only a billion or two working capital. Sofosbuvir is heading for approval in 2014 so it will not be bringing in multi billions until 2014/2015

If gilead would make a deal for Ariad, it would be either stock or some type of more complicated merger which might include making Berger CEO. It's hard to see how an Ariad/Gilead deal would be structured even though it is real easy to hope it happens
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up